CDTX — Cidara Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Cidara Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	50.3	35.9	59.7	32.7	35.8
Net Total Accounts Receivable
Net Total Receivables	5.55	11.2	5.36	5.83	16.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	65.8	57.2	71.7	45.1	60.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.06	1.21	2.54	1.32	5.13
Other Long Term Assets
Total Assets	69	60.4	75.3	47.5	67
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.2	38.6	34	41.4	67.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.1	49.7	53.8	61.9	75.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	37.8	10.7	21.6	-14.4	-8.21
Total Liabilities & Shareholders' Equity	69	60.4	75.3	47.5	67
Total Common Shares Outstanding